Discover Interface, Inc.'s Q3 2025 earnings highlights: strong growth, margin expansion, healthcare gains, and raised full-year guidance.
This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback